KLF1
KLF1, also known as EKLF (erythroid Krueppel-like factor), is a haematopoietic-specific C2H2-type zinc-finger transcription factor that drives erythrocyte development. It activates adult beta-globin and other erythroid genes and helps set the switch from foetal to adult globin expression. Browse Assay Genie's current range of KLF1 research reagents below, or read on for the biology behind the target.
KLF1 is a transcription regulator of erythrocyte development and probably serves as a general switch factor during erythropoiesis. It is a dual regulator of foetal-to-adult globin switching. KLF1 binds the CACCC box in the beta-globin gene promoter and acts as a preferential activator of that gene. It also binds the BCL11A promoter and activates BCL11A expression, and BCL11A in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, foetal haemoglobin levels are low. KLF1 can also activate the CD44 and AQP1 promoters.
The KLF1 gene encodes a haematopoietic-specific zinc-finger protein that belongs to the Krueppel C2H2-type zinc-finger family and to the KLF transcription factor gene group. The protein is found in the nucleus, where it binds the DNA sequence CCACACCCT found in the beta-haemoglobin promoter. Its activity can be switched by post-translational modification: when sumoylated, KLF1 acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta, and it also represses megakaryocytic differentiation. Researchers studying KLF1 protein function therefore often consider both its activating and repressive roles.
The gene was previously named Kruppel-like factor 1 (erythroid), which gives the alias EKLF. Heterozygous loss-of-function mutations in the KLF1 gene result in the dominant In(Lu) blood phenotype. The mouse ortholog is Klf1.
KLF1 is a transcription regulator of erythrocyte development and probably acts as a general switch factor during erythropoiesis.
KLF1 activates beta-globin and BCL11A, and BCL11A represses HBG1 and HBG2, keeping foetal haemoglobin low in most adults.
KLF1 binds CACCC-box DNA and activates promoters including beta-globin, CD44 and AQP1, making it a model for zinc-finger gene control.
Heterozygous loss-of-function mutations in KLF1 result in the dominant In(Lu) blood phenotype.
KLF1 is a transcription regulator of erythrocyte development that probably acts as a general switch factor in erythropoiesis. It activates the beta-globin promoter and BCL11A, which represses HBG1 and HBG2, and it can activate CD44 and AQP1 promoters.
EKLF is an alias of KLF1, derived from the earlier name Kruppel-like factor 1 (erythroid). The current HGNC name is KLF transcription factor 1. Both symbols refer to the same gene and protein, so literature may use either.
Heterozygous loss-of-function mutations in KLF1 result in the dominant In(Lu) blood phenotype. The gene has a mouse ortholog, Klf1; check the datasheet of any product for its validated reactivity.
Other KLF transcription factor family members that share the Krueppel C2H2-type zinc-finger architecture with KLF1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13351; product specifications from Assay Genie datasheets.